Back
Monopar Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.80
Seasonality Move:
-13.48%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 33.43 | Buy |
| 50-day SMA: | 36.97 | Buy |
| 200-day SMA: | 16.52 | Buy |
| 8-day EMA: | 37.22 | Buy |
| 20-day EMA: | 36.12 | Buy |
| 50-day EMA: | 34.54 | Buy |
| 200-day EMA: | 21.18 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 5727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.91 - 40.59) | Buy |
| Bollinger Bands (100): | (18.9 - 39.02) | Buy |
Monopar Therapeutics Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 37.58 while MNPR 8-day simple moving average is 37.17, which is a Buy signal.
-
The stock price of MNPR is 37.58 while Monopar Therapeutics 20-day SMA is 33.43, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 36.97 while MNPR share price is 37.58, making it a Buy technically.
-
MNPR stock price is 37.58 and Monopar Therapeutics 200-day simple moving average is 16.52, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a SellThe current Monopar Therapeutics [MNPR] share price is $37.58. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
198.3M
Price in USD:
37.58
Share Volume:
15.7K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 37.58 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 37.58 while MNPR 8-day exponential moving average is 37.22, which is a Buy signal.
-
The stock price of MNPR is 37.58 while Monopar Therapeutics 20-day EMA is 36.12, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 34.54 while MNPR share price is 37.58, making it a Buy technically.
-
MNPR stock price is 37.58 and Monopar Therapeutics 200-day simple moving average is 21.18, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 0.41, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 53.13, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (29.91 - 40.59), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (18.9 - 39.02), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.